Skip to content
Advertisement

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Overweight and obese adults using popular diabetes medications to suppress their appetites are “significantly more likely" to shed pounds with Eli Lilly's Mounjaro than with Novo Nordisk's Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field. (AP Photo/David J. Phillip, File)

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Overweight and obese adults using popular diabetes medications to suppress their appetites are “significantly more likely" to shed pounds with Eli Lilly's Mounjaro than with Novo Nordisk's Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field. (AP Photo/David J. Phillip, File)

Featured Photo Galleries

Murphy_Giants-2.jpg

Jayden Daniels gets first NFL win as Commanders beat Giants

Led by a single-game franchise-record seven field goals from kicker Austin Seibert, the Washington Commanders defeated the New York Giants 21-18 at Northwest Stadium, Landover, Md., September 15, 2024. (Photos by Brian Murphy for the Washington Times)